IBRANCE 125 mg hard capsules clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, multicenter, open-label study of ribociclib vs. palbociclib in patients with advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer - HARMONIA
This study compares two common breast cancer medicines, Kisqali and IBRANCE, for advanced hormone receptor-positive, HER2-negative or HER2-enriched breast cancer. It looks at how well they stop the cancer from growing and aims to see if one is better than the other.
For: Patients with advanced hormone receptor-positive/HER2- negative/HER2-Enriched breast cancerSpain · Portugal - Ongoing, recruitingTherapeutic exploratory (Phase II)
Phase 2a Study of ZW25 in Combination with Palbociclib Plus Fulvestrant
This study is looking at a new treatment for certain types of advanced breast cancer. It combines a new drug (ZW25) with existing medicines (palbociclib and fulvestrant) to see if it's safe and effective for patients whose cancer has spread or can't be removed by surgery.
For: Breast cancer patients including those with locally advanced (unresectable) or metastatic HER2-positive · HR-positive breast cancerSpain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
MULTISARC : MOLECULAR PROFILING OF ADVANCED SOFT-TISSUE SARCOMAS. A phase III study
This study looks at new ways to treat advanced soft tissue sarcoma, a type of cancer. It uses special tests to check for changes in cancer cells and aims to find the best medicine for each person, making sure these tests are practical and quick enough.
For: Unresectable locally advanced and/or metastatic soft-tissue sarcomaFrance - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1 /2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of amcenestrant (SAR439859 ), administered orally as monotherapy, then in combination with other anti-cancer therapies in postmenopausal women with estrogen receptor-positive advanced breast cancer
This study looks at a new drug, amcenestrant, for postmenopausal women with advanced breast cancer. It tests its safety and how well it works, both alone and with other common cancer medicines.
For: CancerBelgium · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II trial of an individualized treatment strategy for patients with metastatic non-clear cell renal carcinoma
This study is testing different medicines for people with advanced kidney cancer (non-clear cell renal carcinoma) that has spread. It's looking for personalised treatments to see which ones shrink the cancer and how long they keep it under control. The goal is to find better ways to treat this type of cancer.
For: Metastatic non-clear cell renal cell carcinomaDenmark